Le Lézard
Classified in: Health
Subject: CALENDAR OF EVENTS

MedBright AI to Present at CEM Bahamas Small-Cap Conference and Maxim Group's 2024 Healthcare IT Conference


VANCOUVER, British Columbia, Jan. 19, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the "Company" or "MedBright") (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) has announced today that they will be presenting at both the CEM Bahamas Small-Cap Conference, and Maxim Group's 2024 Healthcare IT Conference in the upcoming week.

CEM destination events link public and private issuers with top-tier investors through 1:1 meetings and networking at select venues across North America. MedBright AI is scheduled to have 18 one-on-one meetings with small-cap investment advisors, portfolio managers, institutional investors, and high net worth investors, followed by two days of networking with over 60 qualified prospective investors. The CEM Bahamas event takes place January 18-20, 2024.

Maxim Group's 2024 Healthcare IT Virtual Conference is hosted by Allen Klee, Senior Research Analyst at Maxim Group, and sits down with healthcare IT companies to discuss solutions to improve health outcomes, reduce healthcare costs, benefit healthcare providers, and improve customer experience. This event starts at 9:00 A.M. ET on Wednesday, January 24, 2024. To join this event, please register here.

About MedBright AI Investments Inc.

MedBright AI is a capital allocator focused on investing in healthcare technology companies. The team at MedBright prides themselves on unparalleled access to opportunities, as well as structuring unique and advantageous investments. MedBright's mission is to construct a portfolio of synergistic investments to generate superior returns for shareholders. MedBright will focus on significant near-term and midterm high-quality opportunities with strong return potentials while maintaining commitment to governance. Click here to view the MedBright AI corporate video.

MedBright AI Investments Inc.
Trevor Vieweg, Chief Executive Officer
604-602-0001
Email: [email protected]



These press releases may also interest you

at 08:15
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the first quarter ended March 31, 2024, and provided a business update. "Immunome...

at 08:15
The winners and finalists of Fast Company's 2024 World Changing Ideas Awards were announced today, highlighting fresh sustainability initiatives, cutting-edge AI developments, ambitious pursuits of social equity, and other creative projects that are...

at 08:15
Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today announced that it...

at 08:15
Fresh Del Monte Produce Inc., one of the world's leading vertically integrated producers, marketers, and distributors of high-quality fresh and fresh-cut fruits and vegetables, and Vellsam Materias Bioactivas, a leading producer of biotechnological...

at 08:15
REVEAL GENOMICS, S.L., a Barcelona-based biotechnology start-up seeking to revolutionize precision oncology through biomarker innovation, today announced the forthcoming prospective validation of its groundbreaking diagnostic tool HER2DX® within the...

at 08:10
Allurion Technologies, Inc. ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced its financial results for the first quarter ended March 31, 2024, and provided a business update. Recent Company Highlights First...



News published on and distributed by: